OTC Markets OTCPK - Delayed Quote USD

BioAdaptives, Inc. (BDPT)

Compare
0.0003 0.0000 (0.00%)
At close: November 6 at 3:33 PM EST
Loading Chart for BDPT
DELL
  • Previous Close 0.0003
  • Open 0.0003
  • Bid 0.0002 x --
  • Ask 0.0003 x --
  • Day's Range 0.0002 - 0.0003
  • 52 Week Range 0.0002 - 0.0014
  • Volume 23,997,019
  • Avg. Volume 20,947,071
  • Market Cap (intraday) 369,519
  • Beta (5Y Monthly) 0.25
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

BioAdaptives, Inc. investigates, markets, and distributes natural plant, algal, and mushroom-based products and medical devices for humans and animals. It offers nutraceutical products, such as dietary supplements. The company offers PluriPain, a fast acting long lasting natural pain relief formulation; PrimiLungs; MindNMemory, a nootropic formulation that enhances memory, focus, mental clarity, and endurance; PrimiSleep, a natural soporific that aids relaxation and sleep quality; Cell Rejuven that increases energy and mobility and resistance to stress, activates primitive cells, improves wound healing, and promotes hair and nail growth; and ProteinNMore, which builds lean bulk muscle, and promotes muscle contractility and strength, as well as helps in improving blood flow. It also provides SleepEZ for use as an aid to relaxation; Lung Flute, a medical device, and PrimiLungs, a formulation of nutraceuticals promoting overall health and wellness through support of pulmonary immune systems in its Lung Armor packaging; and animal products, including Equine All-in-One and Equine All-In-One Plus formulation for trainers, horse owners, and boarding stables, as well as a Canine All-in-One that is marketed directly to consumers. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September 2013. BioAdaptives, Inc. was incorporated in 2013 and is based in Las Vegas, Nevada.

www.shopbioadaptives.com

3

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BDPT

View More

Performance Overview: BDPT

Trailing total returns as of 11/6/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BDPT
40.00%
S&P 500
24.30%

1-Year Return

BDPT
72.73%
S&P 500
36.04%

3-Year Return

BDPT
98.70%
S&P 500
26.22%

5-Year Return

BDPT
99.71%
S&P 500
92.84%

Compare To: BDPT

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BDPT

View More

Valuation Measures

Annual
As of 11/6/2024
  • Market Cap

    369.52k

  • Enterprise Value

    719.76k

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.89

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    20.26

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -611.40%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    35.52k

  • Net Income Avi to Common (ttm)

    -771.09k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    235

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    90.58k

Research Analysis: BDPT

View More

Company Insights: BDPT

Research Reports: BDPT

View More

People Also Watch